Clinical Trial

Phase I/II Clinical Trial of Influenza Vaccine (Split Virion), Inactivated (High Dose)

Name: Phase I/II Clinical Trial of Influenza Vaccine (Split Virion), Inactivated (High Dose) — clinical trial record (NCT07737106)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 1

View on ClinicalTrials.gov →

Summary

This is a randomized, double-blind, active-controlled Phase I clinical trial to evaluate the safety and immunogenicity of Influenza Vaccine (Split Virion), Inactivated (High Dose) developed by Sinovac.

Trial Details

NCT Number	NCT07737106
Lead Sponsor	Sinovac Biotech Co., Ltd
Conditions	Influenza
Enrollment	50 participants
Start Date	2025-08-21
Primary Completion	2025-09-18 (estimated)
Study Completion	2026-02-24 (estimated)
Updated on ClinicalTrials.gov	2026-07-30